Open-label, prospective evaluation of adalimumab for psoriasis patients who were nonresponders to etanercept

被引：0
|
作者：
Martyn-Simmons, C. [1 ]
Green, E. [1 ]
Ash, G. [1 ]
Groves, R. [1 ]
Smith, C. H. [1 ]
Barker, J. N. W. N. [1 ]
机构：
[1] St Johns Inst Dermatol, London, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2008年 / 159卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1425 / 1426
页数：2
相关论文
共 50 条
  • [41] Open Label Study to Evaluate the Efficacy of Re-Treatment With Etanercept in Patients With Psoriasis
    Abuchar, Adriana
    Vitiello, Magalys
    Ricotti, Carlos
    Grant, Annika
    Dehesa, Luis
    Kerdel, Francisco
    JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (08) : 950 - 954
  • [42] Relevance of laboratory investigations in monitoring patients with psoriasis on etanercept or adalimumab
    van Lumig, P. P. M.
    Driessen, R. J. B.
    Roelofs-Thijssen, M. A. M. A.
    Boezeman, J. B. M.
    van de Kerkhof, P. C. M.
    de Jong, E. M. G. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (02) : 375 - 382
  • [43] Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab
    van Der Schoot, Lara S.
    Atalay, Selma
    Otero, Marisol E.
    Kievit, Wietske
    van den Reek, Juul M. P. A.
    de Jong, Elke M. G. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (06) : 1028 - 1030
  • [44] Patient-reported outcomes with etanercept therapy in patients with plaque psoriasis who lost response to adalimumab
    Papp, Kim A.
    Tyring, Stephen
    Stolshek, Bradley S.
    Rice, Kara Creamer
    Collier, David H.
    Kricorian, Greg
    Iles, Jan
    Kaliyaperumal, Arunan
    Bagel, Jerry
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB191 - AB191
  • [45] Comparative effectiveness of Adalimumab and Etanercept in patients with chronic plaque psoriasis
    Wilson, J. L.
    Standfield, L.
    Paech, D.
    Sunduram, M.
    Mulani, P.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2012, 53 : 54 - 54
  • [46] Response after 12 weeks of adalimumab therapy in patients with Crohn's disease who were nonresponders at week 4
    Panaccione, Remo
    Sandborn, William
    Colombel, Jean Fred
    Pollack, Paul
    Chen, Naijun
    Chao, Jingdong
    Mulani, Parvez
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S379 - S379
  • [47] Treatment of nail psoriasis with adalimumab: an open label unblinded study
    Rigopoulos, D.
    Gregoriou, S.
    Lazaridou, E.
    Belyayeva, E.
    Apalla, Z.
    Makris, M.
    Katsambas, A.
    Ioannides, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 (05) : 530 - 534
  • [48] Impact of Adalimumab therapy after 12 Weeks in patients with Crohn's Disease who were nonresponders at week 4
    Panaccione, R.
    Sandborn, W.
    Colombel, J.
    Pollack, P.
    Chen, N.
    Chao, J.
    Mulani, P.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S28 - S28
  • [49] Patients with psoriasis respond to continuous open-label etanercept treatment after initial incomplete response in a randomized, placebo-controlled trial
    Krueger, GG
    Elewski, B
    Papp, K
    Wang, A
    Zitnik, R
    Jahreis, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : S112 - S119
  • [50] Intradermal Versus Intramuscular Hepatitis B Vaccination in Hemodialysis Patients: A Prospective Open-Label Randomized Controlled Trial in Nonresponders to Primary Vaccination
    Barraclough, Katherine A.
    Wiggins, Kathryn J.
    Hawley, Carmel M.
    van Eps, Carolyn L.
    Mudge, David W.
    Johnson, David W.
    Whitby, Michael
    Carpenter, Sally
    Playford, E. Geoffrey
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 54 (01) : 95 - 103
12345